U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    APOBEC3B apolipoprotein B mRNA editing enzyme catalytic subunit 3B [ Homo sapiens (human) ]

    Gene ID: 9582, updated on 19-Sep-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    New insights into ATR inhibition in muscle invasive bladder cancer: The role of apolipoprotein B mRNA editing catalytic subunit 3B.

    New insights into ATR inhibition in muscle invasive bladder cancer: The role of apolipoprotein B mRNA editing catalytic subunit 3B.
    Kim H, Cho U, Hong SH, Park HS, Kim IH, An HJ, Shim BY, Kang JH., Free PMC Article

    08/30/2024
    Action-at-a-distance mutations induced by 8-oxo-7,8-dihydroguanine are dependent on APOBEC3.

    Action-at-a-distance mutations induced by 8-oxo-7,8-dihydroguanine are dependent on APOBEC3.
    Fukushima R, Suzuki T, Kobayakawa A, Kamiya H.

    07/2/2024
    Regulatory variants of APOBEC3 genes potentially associate with COVID-19 severity in populations with African ancestry.

    Regulatory variants of APOBEC3 genes potentially associate with COVID-19 severity in populations with African ancestry.
    Zhang K, Chen F, Shen HY, Zhang PP, Gao H, Peng H, Luo YS, Cheng ZS., Free PMC Article

    04/2/2024
    Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations.

    Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations.
    Butt Y, Sakhtemani R, Mohamad-Ramshan R, Lawrence MS, Bhagwat AS., Free PMC Article

    03/20/2024
    The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.

    The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.
    Caswell DR, Gui P, Mayekar MK, Law EK, Pich O, Bailey C, Boumelha J, Kerr DL, Blakely CM, Manabe T, Martinez-Ruiz C, Bakker B, De Dios Palomino Villcas J, I Vokes N, Dietzen M, Angelova M, Gini B, Tamaki W, Allegakoen P, Wu W, Humpton TJ, Hill W, Tomaschko M, Lu WT, Haderk F, Al Bakir M, Nagano A, Gimeno-Valiente F, de Carné Trécesson S, Vendramin R, Barbè V, Mugabo M, Weeden CE, Rowan A, McCoach CE, Almeida B, Green M, Gomez C, Nanjo S, Barbosa D, Moore C, Przewrocka J, Black JRM, Grönroos E, Suarez-Bonnet A, Priestnall SL, Zverev C, Lighterness S, Cormack J, Olivas V, Cech L, Andrews T, Rule B, Jiao Y, Zhang X, Ashford P, Durfee C, Venkatesan S, Temiz NA, Tan L, Larson LK, Argyris PP, Brown WL, Yu EA, Rotow JK, Guha U, Roper N, Yu J, Vogel RI, Thomas NJ, Marra A, Selenica P, Yu H, Bakhoum SF, Chew SK, Reis-Filho JS, Jamal-Hanjani M, Vousden KH, McGranahan N, Van Allen EM, Kanu N, Harris RS, Downward J, Bivona TG, Swanton C., Free PMC Article

    01/27/2024
    Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer.

    Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer.
    Carpenter MA, Temiz NA, Ibrahim MA, Jarvis MC, Brown MR, Argyris PP, Brown WL, Starrett GJ, Yee D, Harris RS., Free PMC Article

    12/21/2023
    Human APOBEC3B promotes tumor development in vivo including signature mutations and metastases.

    Human APOBEC3B promotes tumor development in vivo including signature mutations and metastases.
    Durfee C, Temiz NA, Levin-Klein R, Argyris PP, Alsøe L, Carracedo S, Alonso de la Vega A, Proehl J, Holzhauer AM, Seeman ZJ, Liu X, Lin YT, Vogel RI, Sotillo R, Nilsen H, Harris RS., Free PMC Article

    11/6/2023
    APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer.

    APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer.
    McCann JL, Cristini A, Law EK, Lee SY, Tellier M, Carpenter MA, Beghè C, Kim JJ, Sanchez A, Jarvis MC, Stefanovska B, Temiz NA, Bergstrom EN, Salamango DJ, Brown MR, Murphy S, Alexandrov LB, Miller KM, Gromak N, Harris RS., Free PMC Article

    10/11/2023
    Human cytomegalovirus mediates APOBEC3B relocalization early during infection through a ribonucleotide reductase-independent mechanism.

    Human cytomegalovirus mediates APOBEC3B relocalization early during infection through a ribonucleotide reductase-independent mechanism.
    Fanunza E, Cheng AZ, Auerbach AA, Stefanovska B, Moraes SN, Lokensgard JR, Biolatti M, Dell'Oste V, Bierle CJ, Bresnahan WA, Harris RS., Free PMC Article

    09/6/2023
    The APOBEC3B c.783delG Truncating Mutation Is Not Associated with an Increased Risk of Breast Cancer in the Polish Population.

    The APOBEC3B c.783delG Truncating Mutation Is Not Associated with an Increased Risk of Breast Cancer in the Polish Population.
    Gliniewicz K, Kluźniak W, Wokołorczyk D, Huzarski T, Stempa K, Rudnicka H, Jakubowska A, Szwiec M, Jarkiewicz-Tretyn J, Naczk M, Kluz T, Dębniak T, Gronwald J, Lubiński J, Narod SA, Akbari MR, Cybulski C., Free PMC Article

    08/9/2023
    APOBEC3B coordinates R-loop to promote replication stress and sensitize cancer cells to ATR/Chk1 inhibitors.

    APOBEC3B coordinates R-loop to promote replication stress and sensitize cancer cells to ATR/Chk1 inhibitors.
    Zong C, Zhang Z, Gao L, He J, Wang Y, Li Q, Liu X, Yang J, Chen D, Huang R, Zheng G, Jin X, Wei W, Jia R, Shen J., Free PMC Article

    06/8/2023
    APOBEC3B stratifies ovarian clear cell carcinoma with distinct immunophenotype and prognosis.

    APOBEC3B stratifies ovarian clear cell carcinoma with distinct immunophenotype and prognosis.
    Long X, Lu H, Cai MC, Zang J, Zhang Z, Wu J, Liu X, Cheng L, Cheng J, Cheung LWT, Shen Z, Zhou Y, Di W, Zhuang G, Yin X., Free PMC Article

    05/28/2023
    Aberrant APOBEC3B Expression in Breast Cancer Is Linked to Proliferation and Cell Cycle Phase.

    Aberrant APOBEC3B Expression in Breast Cancer Is Linked to Proliferation and Cell Cycle Phase.
    Roelofs PA, Timmermans MAM, Stefanovska B, den Boestert MA, van den Borne AWM, Balcioglu HE, Trapman AM, Harris RS, Martens JWM, Span PN., Free PMC Article

    05/23/2023
    APOBEC3B expression is promoted by lincNMR collaborating with TGF-beta-Smad pathway.

    APOBEC3B expression is promoted by lincNMR collaborating with TGF-β-Smad pathway.
    Ota K, Sakai S, Ohhata T, Suzuki T, Uchida C, Niida H, Kitagawa M.

    05/17/2023
    APOBEC3A/B deletion polymorphism and endometrial cancer risk.

    APOBEC3A/B deletion polymorphism and endometrial cancer risk.
    Sofiyeva N, Krakstad C, Halle MK, O'Mara TA, Romundstad P, Hveem K, Vatten L, Lønning PE, Gansmo LB, Knappskog S., Free PMC Article

    04/5/2023
    APOBEC3B drives PKR-mediated translation shutdown and protects stress granules in response to viral infection.

    APOBEC3B drives PKR-mediated translation shutdown and protects stress granules in response to viral infection.
    Manjunath L, Oh S, Ortega P, Bouin A, Bournique E, Sanchez A, Martensen PM, Auerbach AA, Becker JT, Seldin M, Harris RS, Semler BL, Buisson R., Free PMC Article

    02/16/2023
    Primary mucosal melanomas of the head and neck are characterised by overexpression of the DNA mutating enzyme APOBEC3B.

    Primary mucosal melanomas of the head and neck are characterised by overexpression of the DNA mutating enzyme APOBEC3B.
    Argyris PP, Naumann J, Jarvis MC, Wilkinson PE, Ho DP, Islam MN, Bhattacharyya I, Gopalakrishnan R, Li F, Koutlas IG, Giubellino A, Harris RS., Free PMC Article

    02/13/2023
    High APOBEC3B mRNA Expression Is Associated with Human Papillomavirus Type 18 Infection in Cervical Cancer.

    High APOBEC3B mRNA Expression Is Associated with Human Papillomavirus Type 18 Infection in Cervical Cancer.
    de Oliveira GR, Carvalho PS, Vieira VC, Curty G, Basto DL, Moreira MÂM, Soares MA., Free PMC Article

    01/11/2023
    G1/S Cell Cycle Induction by Epstein-Barr Virus BORF2 Is Mediated by P53 and APOBEC3B.

    G(1)/S Cell Cycle Induction by Epstein-Barr Virus BORF2 Is Mediated by P53 and APOBEC3B.
    Yockteng-Melgar J, Shire K, Cheng AZ, Malik-Soni N, Harris RS, Frappier L., Free PMC Article

    10/22/2022
    Multiple roles of apolipoprotein B mRNA editing enzyme catalytic subunit 3B (APOBEC3B) in human tumors: a pan-cancer analysis.

    Multiple roles of apolipoprotein B mRNA editing enzyme catalytic subunit 3B (APOBEC3B) in human tumors: a pan-cancer analysis.
    Wu J, Li N, Zhu L, Zhen D, Li M, Chen H, Ye M, Wei Y, Shao G., Free PMC Article

    08/27/2022
    APOBEC mutagenesis and selection for NFE2L2 contribute to the origin of lung squamous-cell carcinoma.

    APOBEC mutagenesis and selection for NFE2L2 contribute to the origin of lung squamous-cell carcinoma.
    Cannataro VL, Kudalkar S, Dasari K, Gaffney SG, Lazowski HM, Jackson LK, Yildiz I, Das RK, Gould Rothberg BE, Anderson KS, Townsend JP., Free PMC Article

    08/27/2022
    Prognostic Value of HPV E6 and APOBEC3B in Upper Urinary Tract Urothelial Carcinoma.

    Prognostic Value of HPV E6 and APOBEC3B in Upper Urinary Tract Urothelial Carcinoma.
    He L, Yang B, Jian D, Luo H, Wang D, Dai N., Free PMC Article

    08/6/2022
    Evaluation of APOBEC3 expression as prognostic marker in squamous cell carcinoma of the penis.

    Evaluation of APOBEC3 expression as prognostic marker in squamous cell carcinoma of the penis.
    Trimmel B, Oszwald A, Diemand C, Ertl IE, Lemberger U, Bruchbacher A, Brettner R, Korn S, Resch I, Comperat E, Shariat SF, Hassler MR., Free PMC Article

    08/6/2022
    Mechanisms of APOBEC3 mutagenesis in human cancer cells.

    Mechanisms of APOBEC3 mutagenesis in human cancer cells.
    Petljak M, Dananberg A, Chu K, Bergstrom EN, Striepen J, von Morgen P, Chen Y, Shah H, Sale JE, Alexandrov LB, Stratton MR, Maciejowski J., Free PMC Article

    08/6/2022
    IFN-gammaInduced APOBEC3B Contributes to Merkel Cell Polyomavirus Genome Mutagenesis in Merkel Cell Carcinoma.

    IFN-γ‒Induced APOBEC3B Contributes to Merkel Cell Polyomavirus Genome Mutagenesis in Merkel Cell Carcinoma.
    Que L, Li Y, Dainichi T, Kukimoto I, Nishiyama T, Nakano Y, Shima K, Suzuki T, Sato Y, Horike S, Aizaki H, Watashi K, Kato T, Aly HH, Watanabe N, Kabashima K, Wakae K, Muramatsu M.

    06/25/2022
    firstprevious page of 7 nextlast